The TREX1-associated microglial phenotype was rescued to control conditions upon treatment with atorvastatin – an FDA-approved HMG-CoA reductase inhibitor commonly used to treat hypercholesterolemia. Here, HMGCR is linked to familial hypercholesterolemia.